Fortress Biotech, Inc.
FBIO
$2.72
$0.010.37%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.84M | 15.92M | 16.07M | 17.03M | 15.01M |
| Total Other Revenue | 879.00K | 117.00K | 13.00K | 606.00K | 1.40M |
| Total Revenue | 18.72M | 16.04M | 16.08M | 17.63M | 16.41M |
| Cost of Revenue | 6.95M | 6.76M | 5.07M | 5.96M | 13.07M |
| Gross Profit | 11.77M | 9.28M | 11.01M | 11.67M | 3.35M |
| SG&A Expenses | 20.81M | 15.89M | 14.73M | 17.42M | 38.76M |
| Depreciation & Amortization | 969.00K | 1.13M | 1.07M | 1.06M | 1.06M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.72M | 23.78M | 20.87M | 24.44M | 52.89M |
| Operating Income | -10.01M | -7.74M | -4.79M | -6.81M | -36.47M |
| Income Before Tax | 922.00K | 142.29M | -6.21M | 8.85M | -11.65M |
| Income Tax Expenses | 320.00K | 5.13M | -816.00K | 26.00K | -- |
| Earnings from Continuing Operations | 602.00K | 137.16M | -5.40M | 8.83M | -11.65M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.07M | -26.79M | 1.46M | -2.98M | 27.14M |
| Net Income | -468.00K | 110.37M | -3.94M | 5.85M | 15.49M |
| EBIT | -10.01M | -7.74M | -4.79M | -6.81M | -36.47M |
| EBITDA | -8.94M | -6.52M | -3.63M | -5.65M | -35.32M |
| EPS Basic | -0.08 | 3.44 | -0.20 | 0.13 | 0.50 |
| Normalized Basic EPS | -0.02 | 1.97 | -0.08 | 0.44 | 0.11 |
| EPS Diluted | -0.08 | 2.82 | -0.20 | 0.11 | 0.45 |
| Normalized Diluted EPS | -0.02 | 1.62 | -0.08 | 0.36 | 0.10 |
| Average Basic Shares Outstanding | 31.79M | 31.54M | 30.38M | 27.24M | 26.88M |
| Average Diluted Shares Outstanding | 31.79M | 38.41M | 30.38M | 33.10M | 29.82M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |